Careers  |  Sign In  |  Register

Latest in Travel Medicine

ZMapp manufacturer Mapp Biopharmaceutical announced that its current supply of the experimental Ebola drug known as ZMapp has been exhausted, according to an article published by CBS News. The cost-free antibody drug was the most widely used experimental treatment, however several others are still in the...
An experimental vaccine developed by Canadian scientists at NewLink Genetics Corporation is on the verge of launching its first human clinical trial, according to a report by Reuters. The new drug uses the pathogen vesicular stomatitis virus,where one virus gene is replaced by an Ebola gene, which then...
A second experimental Ebola drug from Tekemira Pharmaceuticals is advancing through clinical trials from healthy volunteers to affected patients in Africa thanks to help from the FDA, the New York Times reports. Last month, the FDA had stopped the trial for TKM-Ebola because of side effects, but taking into...